Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$172.58 - $196.48 $138,064 - $157,184
-800 Reduced 3.85%
20,000 $3.91 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $1.91 Million - $2.34 Million
13,100 Added 170.13%
20,800 $3.61 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $381,041 - $459,862
2,300 Added 42.59%
7,700 $1.3 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $4.24 Million - $5.6 Million
-28,000 Reduced 83.83%
5,400 $1.07 Million
Q3 2023

Nov 15, 2023

BUY
$167.14 - $192.77 $5.58 Million - $6.44 Million
33,400 New
33,400 $5.81 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.